CD33 and Alzheimer disease: Although it is still unclear to what extent peripheral myeloid cells engraft in the AD brain, it has been observed that CD33 expression levels are increased in CNS, but appeared decreased in peripheral mononuclear cells of AD patients [47], suggesting that central and peripheral myeloid cell frequency may be linked processes during the disease.